Graphical abstract
Keywords: Glycoprotein hormone receptors, G protein-coupled receptors, Molecular dynamics simulation, Protein dynamics, Evolutionary analysis
Abstract
Luteinizing hormone-choriogonadotropin receptor (LHCGR), a class A G protein-coupled receptor (GPCR), plays a pivotal role in the maturation of reproductive organs and embryonic development. Compared with other GPCRs, the subfamily of LHCGR has a large extracellular domain (ECD) to interact with glycoprotein hormones. A unique hinge region connects the ECD and transmembrane domain (TMD) to transfer the activation signal. However, the signal transmission mechanism remains largely unknown. Here, both molecular dynamics simulation and evolutional analysis were applied to explore the effect of the hinge region on signal transmission. The glycoprotein hormone determined specific hinge region conformations, including the position of a long hinge loop and the ECD-TMD interface. With the hormone, the hinge region showed a characteristic rotation and displayed an active-like conformational landscape of the ECD-TMD interface with an extended TMD. The active-like hinge region conformation transduces the hormone binding signal downwards from ECD to TMD. The relationship between the hinge region and the intracelluar G protein-binding pocket was also inferred. The hinge region-mediated signal transmission mechanism offers a deeper understanding of LHCGR and provides insights into the elucidation of GPCR activation.
1. Introduction
As a subfamily of class A G protein-coupled receptors (GPCRs), glycoprotein hormone receptors (GPHRs) were membrane proteins activated by endogenous agonists on their unique large extracellular domain (ECD) and induce intracellular signals through their transmembrane domain (TMD) [1], [2]. GPHRs include gonadotropin receptors, namely follicle-stimulating hormone (FSH) receptor (FSHR) and luteinizing hormone (LH) /choriogonadotropin (CG) receptor (LHCGR). Gonadotropin receptors are situated at the surface of gonadal cells and play pivotal roles in the function of the reproductive system [3]. In particular, LHCGR is activated by both LH and CG, and regulates the maturity of germ cells and embryo development, respectively [4], [5]. Human CG is used as the gold standard for pregnancy diagnosis. Moreover, it is also employed as a tumor marker, amyloid-β precursor, as well as a potential pre-drug for cancers [6], [7], [8]. The dysfunction of LHCGR causes hormone secretion disorders. For example, its inactivating mutation E354K induces inherited pseudohermaphroditism [9], while the activating mutation L457R causes testotoxicosis and oligozoospermia [10]. Thus, the elucidation of the LHCGR mechanism not only helps the understanding of GPCR function, but also provides hints for infertility and glycoprotein hormone-related drug design.
Compared with other class A GPCRs, a unique property of LHCGR is the large ECD that contains 340–420 amino acids and binds to a large agonist of glycoprotein hormone with around 200 amino acids [3], [11]. The ECD consists of a leucine-rich repeat (LRR) and a hinge region. The LRR contains a structure composed of repeated β-sheets and loosen loops, which is different from the combined ⍺-helices and β-sheets in ECD of class B GPCRs [12], [13]. The hinge region is composed of a hinge helix, a long hinge loop, and a highly conserved P10 loop in GPHRs [14]. The hinge helix and P10 loop directly interact with TMD [15]. The unique ECD and hinge region suggest a distinct signal transmission mechanism of LHCGR in class A GPCRs. Recently, the full-length active LHCGR-CG-G protein structures were solved, suggesting a push-and-pull model in the activation of LHCGR [15]. In the push-and-pull model, the CG may activate the receptor by pushing the ECD to be vertical to the membrane plane, and the hinge loop pulls the CG-bound ECD to stabilize the activated conformation. However, the complex lacks the hinge loop due to its flexibility but the integrity of the hinge loop is necessary for LHCGR activation [15], [16]. The mechanism of how signal transfers through the hinge region remains unknown for this important drug target.
Here, molecular dynamics (MD) simulation and evolutional analysis were combined to characterize the hinge region movements of LHCGR. Repeated 500 ns MD simulations were performed for LHCGR-only, CG-bound LHCGR, and CG-bound LHCGR-Gs complex. We also explored the dynamics of important LHCGR mutants (S277I and E354K) to elucidate the activation or inactivation mechanism. Besides, the relationship between hinge and TMD movements was evaluated by statistic coupled analysis and protein dynamics.
2. Materials and methods
2.1. System setup
The cryo-EM structure of the CG-bound LHCGR-Gs complex (PDB ID: 7FIG) was downloaded from the Protein Data Bank. Then, mutations on LHCGR were reverted to the wild type using maestro of the Schrödinger suite and missing loops were made up referring to the homology model provided by the Swissmodel web server [17]. The protonation state of each residue was calculated by propka3 and the post-translational modifications of the system were kept the same as the cryo-EM structure [18].
To build the LHCGR-CG system, we deleted the G protein in the CG-bound LHCGR-Gs complex, and further deleted CG for the construction of the LHCGR-only system. From the LHCGR-only system, we made S277I and E354K mutations for the construction of corresponding mutated systems.
Referring to class A GPCRs, we oriented the structures locally and then submitted them to CHARMM-GUI to insert them into a membrane, composed of 137×137 Å2 POPC (palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) lipids [19], [20], [21]. TIP3P (transferable intermolecular potential 3P) water molecules with a length of 22.5 Å were added to the top and bottom of the system. Then, 0.15 mol/L KCl plus the same counterions were placed in each system via the distance method. After the assembly of each component, the CHARMM36m force field was applied to describe amino acids and lipids [22].
2.2. Molecular dynamics simulations
The systems firstly encountered a minimization process of 5000 steepest descent cycles with a constraint on the backbone atom, sidechain atom, and lipid coordinates and a constraint on dihedrals. Then, the constraints were generally decreased in the separated 6 steps of the equilibration process provided by CHARMM-GUI. The first three of them had a timestep of 1 fs and heated the system to 303.15 K, 1 atm in 375 ps. The last three of them had 2 fs timestep, maintaining the temperature and pressure in 1.5 ns. In the 6 steps, constraints on residue pose were generally decreased.
After the equilibration, systems were submitted to 3 × 500 ns production runs. The productions were performed in the NPT ensemble at a temperature of 303.15 K and a pressure of 1 atm, which were controlled by the Nose-Hoover thermostat and Parrinello–Rahman barostat with isotropic coupling, respectively [23], [24]. Since all hydrogen-containing bonds were restricted by the LINCS algorithm, the timestep for the production run was set to 2 fs [25]. A nonbonded pairlist for each atom was generated every 20 steps using a distance cutoff of 12 Å. Smoothly switched off between 12 and 10 Å, the Van der Waals interactions were calculated by a cutoff of 12 Å upper limit. The Particle-Mesh-Ewald algorithm was applied to calculate electrostatic interactions with a grid size of 1 Å and short-range electronic interactions were calculated with a cutoff of 12 Å [26]. All simulations were carried out by GROMACS 5.1.4 [27].
2.3. Trajectory analysis
Trajectory analysis was performed by GROMACS and Amber suites. To calculate relative X and relative Y, we first extracted pdb structures on each trajectory via the “trajconv” command in GROMACS. Then, according to the TMD structure, all structures were aligned to the cryo-EM LHCGR-CG-G structure oriented on the X-Y surface. At last, the average coordinate of C⍺ atoms for Y331-G334 and the coordinate of T4463.32 were extracted. The final relative X and Y values were the difference in X and Y coordinates in the former and latter items.
With the hieragglo algorithm on the snapshots in our representative rectangles, the extract of the representative models used the “cluster” command in Amber CPPTRAJ [28]. SASA was estimated by the “surf” command in Amber CPPTRAJ with the linear combination of pairwise overlaps method (LCPO) [29]. The interaction frequency referred to the minimal distance for non-hydrogen atoms in residue pair or atom pair during simulations, while the minimal distance was calculated by the “nativecontact” command in Amber CPPTRAJ. 3D scatter plots were drawn by MATLAB. Using the aligned pdb structures in the calculation of relative X and Y, pocket volume was measured by POVME [30]. DCCM was calculated by the “matrix” command in Amber CPPTRAJ.
2.4. Statistics coupled analysis (SCA)
Multiple sequence alignments (MSA) of LHCGR were carried out based on the alignment module of the GPCRdb database [31]. All sources and all species available LHCGR and FSHR sequences were aligned and justified to ensure that no gap exists in the human sequence. In total, 208 sequences and a row of gaps to prevent the zero-frequency problem were set as input for LHCGR SCA, while FSHR used 330 sequences [32]. Logoplots were drawn by WebLogo [33].
In the SCA process, the cross-entropy between the actual amino acid frequency at position i () and background frequency for this residue () was estimated to calculate the conservation level () at this site. The calculation refers to
| [1] |
In each position, was calculated by the most frequent residue. Then, the correlations between positions i and j with the mostly emerged residue a and b, namely was estimated by Equation [2].
| [2] |
in which means the frequency that position i has residue a and in the meantime, position j has residue b. values made up of the SCA matrix in Fig. 5.
Fig. 5.
SCA analysis and sector division. (A) SCA matrix for LHCGR. The residue number is referred to as the human sequence. White rectangles show TMD residues that are highly related to ECD. (B) Three major sectors for LHCGR. Protein is shown in cartoon depict. Sectors are shown as sticks on the cryo-EM LHCGR (PDB code: 7FIG) [15]. (C) SCA matrix for FSHR. (D) Three major sectors for FSHR. Sectors are shown as sticks on the structure predicted by AlphaFold2 [35].
The eigenvectors of the SCA matrix were then calculated to identify the evolutional-related residues (sectors). Since the first mode shows the global fluctuations between species and mutants, it was deprecated in the search for sectors [34]. In the application of LHCGR and FSHR, we set the threshold value ε as 0.035–0.05 dependent on the distribution of sectors. We identified the positions whose weight of the 2nd eigenvector is larger than the weight of the 4th eigenvector and larger than ε as one sector, the positions whose weight of the 2nd eigenvector is smaller than the weight of the 4th eigenvector and -ε as the other sector, and the positions whose weight of 4th eigenvector is larger than the weight of the 2nd eigenvector and larger than ε as the last sector. Then, the sectors were renumbered to match the relative position in LHCGR and FSHR. The FSHR structure model was obtained from AlphaFold2 database [35]. The sector choosing and SCA calculation were confirmed in previous publications [32], [34], [36].
3. Results
3.1. Rotation of hinge loop with agonist binding
To investigate the effects of agonist binding on LHCGR, we performed MD simulations of the LHCGR with and without the endogenous agonist CG, termed LHCGR-CG and LHCGR-only, respectively. We also conducted simulations of LHCGR bound to CG and G protein as a control group, termed LHCGR-CG-G. All protein models were generated using the cryo-EM structure of the LHCGR-CG-Gs complex as the template (PDB ID: 7FIG) [15].
LHCGR uses a LRR to receive the agonist signal, a hinge region to transfer the signal, and a TMD to bind G protein (Fig. 1A, B). Particularly, the hinge region includes a hinge helix (residues 276–282), a hinge loop (residues 284–340), and a P10 loop (residues 350–359) (Fig. 1A). To characterize the system stability, we calculated the root mean square deviation (RMSD) from the starting conformation of the whole receptor and its subdomains, respectively (Figure S1 and Table S1). RMSD of all systems became stable after 50 ns, indicating the equilibrium of systems. Compared with CG-bound systems, LHCGR-only had a higher ECD RMSD value of 9.5 ± 1.1 Å, but a similar TMD RMSD value of 3.2 ± 0.4 Å (Table S1). As a component of ECD, the hinge loop showed remarkably high RMSDs (9.6 ± 1.2 Å for LHCGR-CG-G, 8.8 ± 2.0 Å for LHCGR-CG, and 11.5 ± 2.5 Å for LHCGR-only). The ECD RMSDs decreased by removing the hinge loop in all systems (Table S1). These findings suggested large movements or conformational changes of the hinge loops in simulations. As for the P10 loop and hinge helix, RMSD increased from LHCGR-CG-G protein, LHCGR-CG, to LHCGR-only systems (Table S1), suggesting both CG and G protein stabilized these regions.
Fig. 1.
(A) Schematic diagram of LHCGR. (B) Molecular model showing structure components of LHCGR. Protein is shown in cartoon depict. (C, D) The free energy landscape for relative X and relative Y coordinates of C⍺ atoms of hinge loop residues (Y331-G334) with respect to the coordinate of T4463.32 in LHCGR-only (C) and LHCGR-CG (D) systems. Rectangles show the dominant conformations of the landscape. (E, F) The representative models showing dominant hinge loop conformations in LHCGR-only (E) and LHCGR-CG (F) systems. Red arrows show hinge loop residues (Y331-G334). The hinge loop is highlighted in deep teal. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
We observed movements of the hinge loop in the LHCGR-only simulations. To quantify the movements, we projected the C⍺-atom coordinates of four hinge loop residues (Y331-G334, red arrows in Fig. 1E) to the membrane (XY-plane) to quantify the movements. Then, their relative X and Y coordinates with respect to the C⍺ atom of T4463.32 (The superscripts refer to the Ballesteros–Weinstein numbering system) were calculated to show the position of the hinge loop. As shown in Fig. 1C, the hinge loop of LHCGR-only had a large population around (0 Å, −27 Å). However, LHCGR-CG had a relative X value larger than 10 Å and a relative Y value larger than −20 Å in most populations (Fig. 1D). Similar dominant conformations of the hinge loop were also observed in the LHCGR-CG-G system (Figure S2). Compared with that of LHCGR-only, the hinge loop of LHCGR-CG moved from the membrane side of TM6 to the position above TM5 and had a 90° clockwise rotation (Fig. 1E).
We observed that the hinge loop formed coiled conformations in the LHCGR-only system, characterized by decreased solvent accessible surface areas (SASA) of the hinge loop. In LHCGR-only simulations, the SASA of the hinge loop decreased from 7276 Å2 to approximately 5500 Å2 within 300 ns (Fig. S3A). Meanwhile, with an extended conformation, the hinge loop of CG-bound LHCGR maintained a stable large SASA around 6700 Å2 (Fig. S3B). In the LHCGR-only system, the reduced SASA indicated a diminished surface exposed to solvent, due to the coiled hinge loop of LHCGR-only. Particularly, R283, L326, W329, C336, P338, and K339 showed smaller SASAs in the LHCGR-only system by forming additional interactions (Fig. S3C, D).
3.2. Alteration of ECD-TMD interface
As two components of the hinge region, the hinge helix and P10 loop are linked by the hinge loop and form the interface of ECD-TMD (Fig. 1A, B). In simulations, we observed the movements of this interface (termed hinge helix-P10 loop) with respect to extracellular loop 1 (ECL1) in Fig. 2. We observed different interactions between A281Hinge helix and N428ECL1 as well as between E354P10 and Y426ECL1 in LHCGR-only and LHCGR-CG systems, suggesting conformational changes of ECD-TMD interfaces. E354 plays an important role in receptor activation [9]. Thus, the minimal distance between A281Hinge helix and N428ECL1 (dHinge helix-ECL1) and between E354P10 and Y426ECL1 (dP10-ECL1) were measured to show the position of hinge helix-P10 loop with respect to ECL1 (Fig. 2). 79.31 % conformations of the LHCGR-only have dHinge helix-ECL1 larger than 4 Å (Fig. 2A, C), suggesting reduced interactions between hinge helix and ECL1. In contrast, in LHCGR-CG, most conformations had dHinge helix-ECL1 less than 4 Å, suggesting stable direct interactions between hinge helix and ECL1(Fig. 2B, D). Meanwhile, dP10-ECL1 was mostly smaller than 4 Å in the LHCGR-only (Fig. 2A, C), but larger than 4 Å in LHCGR-CG (Fig. 2B, D). These findings indicate that LHCGR-only had hinge helix move away from ECL1 but had P10 loop directly interact with it, which was an inactive-like conformation compared with the active-like CG-bound LHCGR. It is worth mentioning that most LHCGR with a rotated hinge loop had large dP10-ECL1 and small dHinge helix-ECL1 (Figure S4, S5), suggesting that such movements of the hinge helix-P10 loop were accompanied by the hinge loop rotation.
Fig. 2.
Hinge helix-P10 loop in LHCGR-only and LHCGR-CG systems. (A, B) The free energy landscape for the minimal distance between E354P10 and Y426ECL1 (dP10-ECL1) and the minimal distance between A281Hinge helix and N428ECL1 (dHinge helix-ECL1) in LHCGR-only (A) and LHCGR-CG (B) systems. Rectangles show the dominant conformations of the landscapes. (C, D) Representative models showing interactions between hinge helix, P10 loop, and ECL1 in LHCGR-only (C) and LHCGR-CG (D) systems. Protein and key residues are shown in cartoon and stick depicts, respectively.
Previous work had revealed a constitutively active mutation, i.e. S277I, on the hinge helix [15], [37]. Moreover, a mutation on the P10 loop, i.e. E354K, was identified to diminish the activity of LHCGR [9]. To characterize these functionally important mutations in the hinge helix-P10 loop domain, we performed MD simulations for S277I and E354K mutants (termed LHCGR-S277I and LHCGR-E354K), respectively. The positions of these two residues are shown in Fig. 3A. In LHCGR-S277I, we observed a population of receptor comformations with dHinge helix-ECL1 between 3 Å and 4 Å and dP10-ECL1 between 4 Å and 6 Å (Fig. 3B), similar to those of active-like LHCGR-CG (Fig. 2B). In contrast, LHCGR-E354K had its P10 move towards ECL1 (Fig. 3C), which was distinct from active-like conformations of LHCGR-CG (Fig. 2B). We then investigated how S277I and E354K mutations influence hinge helix-P10 conformation (Fig. 3D-I and Figure S6). For the S277I mutation, the WT representative model extended the sidechain of S277Hinge helix opposite with I431ECL1 (Fig. 3D). The minimal distance between S277Hinge helix and I431ECL1 is 7.6 Å. In contrast, I277Hinge helix made hydrophobic contact with I431ECL1 in the mutated system (Fig. 3E). Globally, LHCGR-S277I had more dS277-I431 sampled in 3–5 Å (96.0 %) than LHCGR-only (75.5 %), suggesting increasing hydrophobic contacts between I277Hinge helix and I431ECL1 (Fig. 3F).
Fig. 3.
The effects of mutations on the hinge helix-P10 loop conformations. (A) S277 Hinge helix and E354 P10 of LHCGR. Protein and key residues are shown in cartoon and stick depicts, respectively. (B, C) The free energy landscape for the minimal distance between E354P10 and Y426ECL1 (dP10-ECL1) and the minimal distance between A281Hinge helix and N428ECL1 (dHinge helix-ECL1) in LHCGR-S277I (B) and LHCGR-E354K (C) systems. (D, E) Representative models showing interactions between hinge helix and ECL1 in LHCGR-only (D) and LHCGR-S277I (E) systems. (F) Distribution of the minimal distance between S/I277Hinge helix and I431ECL1 in LHCGR-only and LHCGR-S277I systems. (G, H) Representative models showing interactions between P10 loop, TMD, and ECL1 in LHCGR-only (G) and LHCGR-E354K (H) systems. (I) Distribution of the minimal distance between E/K354P10 and K6057.35 in LHCGR-only and LHCGR-E354K systems.
As for E354K, K354P10 made P10 loop closer to ECL1 (Fig. 3G, 3H). The WT system had its dE354-K605 concentrated on 2–4 Å (58.9 %, Fig. 3I). Conversely, the E354K mutation led to 90.2 % snapshots with a dK354-K605 value larger than 4 Å (Fig. 3I). The cryo-EM structure showed a similar tendency with WT trajectories, including far S277Hinge helix-I431ECL1 and close E354P10-K6057.35 (Figure S7). Thus, activating mutation S277I led to a closer hinge helix and ECL1 via hydrophobic contact with I431ECL1. The inactivating mutation E354K caused P10 conformation closer to ECL1. The effect can be attributed to the electrostatic repulsion effect with K6057.35. Taken together, our definitions of interface conformations matched the mutation effects and thus explain the mutations in this domain.
3.3. TMD expansion during activation
Since both the hinge helix and P10 loop directly interact with ECLs, we investigated the effects of the hinge helix-P10 domain on TMD conformations. In simulations, LHCGR-CG showed a larger distance between TM6 and TM7, compared with the LHCGR-only (Fig. 4A, B, Table 1). At the extracellular side of TM6 and TM7, the average distance between the C⍺ atoms of A5926.58 and K6057.35 (dA592-K605) was 7.7 ± 3.5 Å in LHCGR-only simulations, which was approximately 5 Å shorter than that in LHCGR-CG simulations (12.9 ± 1.3 Å for CG, 12.1 ± 1.5 Å for CG-G) (Fig. 4A). The movements of TM6 and TM7 also transferred to the middle of TMD (Fig. 4B). At the middle regions of these helices, the C⍺-atom distance between C5816.47 and N6157.45 (dC581-N615) was 7.2 ± 0.9 Å of LHCGR-only, which was also shorter than that of LHCGR-CG (8.5 ± 0.2 Å) and LHCGR-CG-G (8.7 ± 1.2 Å) (Fig. 4B). As shown in Figure S8, LHCGR-only had a shorter extracellular TM6-TM7 distance than LHCGR-CG in the dominant hinge helix-P10 conformation, suggesting the coupling between the TMD expansion and hinge helix-P10 conformation.
Fig. 4.
Different conformations of TMD in simulations. (A, B) Representative models showing the extracellular TM6-TM7 movements. Protein and key residues are shown in cartoon and stick depicts, respectively. (C) The major small-molecule binding pockets in LHCGR-only and LHCGR-CG systems. (D) M5826.48 in LHCGR-only and LHCGR-CG systems.
Table 1.
The properties showing different TMD conformations in simulation systems.
| Properties | LHCGR-CG-G | LHCGR-CG | LHCGR-only |
|---|---|---|---|
| dA592-K605 | 12.1 ± 1.5 Å | 12.9 ± 1.3 Å | 7.7 ± 3.5 Å |
| dC581-N615 | 8.7 ± 1.2 Å | 8.5 ± 0.8 Å | 7.2 ± 0.9 Å |
| volume | 313.03 ± 162.09 Å3 | 253.7 ± 121.1 Å3 | 188.4 ± 111.3 Å3 |
| Flipped-up M5826.48 | 56.4 % | 49.1 % | 32.3 % |
| Flipped-down M5826.48 | 43.6 % | 50.9 % | 67.7 % |
The TM6 and TM7 participate in forming a transmembrane pocket, corresponding to the major small molecule-binding pocket of classical family A GPCRs [38], [39]. The size of such pocket directly correlates with GPCR activation [40]. We found that the size of the small molecule-binding pocket increased with CG binding (Fig. 4C, Table 1). LHCGR-CG had a long TM6-TM7 distance and an extended pocket towards extracellular TM2-TM3. The active-like P10 conformation also permitted an extra volume above the TMD of LHCGR-CG. These properties led to an average volume of 253.7 ± 121.1 Å3. However, the upward movements of the hinge helix in LHCGR-only caused ECL1 and TM2-TM3 to depart from the bundle center, while the P10 loop failed to form a pocket with TMD due to its upward movement. The closer TM6-TM7 distance contributed to a more contracted pocket with an average volume of 188.4 ± 111.3 Å3. The large volume of pocket was also observed in the active-state simulation of LHCGR-CG-G (313.03 ± 162.09 Å3).
The extended TM6-TM7 also altered the sidechain contact of highly conserved M5826.48 in GPHRs (Fig. 4D). In LHCGR-CG, M5826.48 flipped upward to interact with L5325.44 (Fig. 4D). The minimal distance between M5826.48 and L5325.44 was 4.5 Å. However, in LHCGR-only, it flipped downward and contacted with F5395.51 and L4573.43 with minimal distances of 4.2 Å and 4.3 Å (Fig. 4D). In all simulations, LHCGR-only had more flipped-down M5826.48 (67.7 %) than LHCGR-CG (50.9 %). In LHCGR-CG-G simulations, the population of flipped-down M5826.48 further decreased to 43.6 % (Table 1). The interaction between the flipped-down M5826.48 and L4573.43 on the opposite of TMD might induce the closure of TM6. Consistently, previous clinical research reported that L457R mutation led to LHCGR activation, which may be attributed to the disruption of hydrophobic interaction with M5826.48 [10].
3.4. Evolutionary and dynamics analysis show correlations between the hinge region and the other subdomains
We applied evolutionary and dynamics relationship analysis to build connections between the aforementioned movements and the intracellular pocket for G protein binding. The G protein-binding pocket locates in the intracellular side of TMD and its opening depends on the movement of TMs 5–7 [41], [42]. Since LHCGR has a close homolog FSHR with similar structure composition and mechanism [15], we also did an evolutionary analysis on FSHR for reference. Statistic coupled analysis (SCA) models of LHCGR and FSHR were constructed. SCA is based on the deviation degree of residue frequency on the protein from the background frequency and calculates the correlation constant () for position i with residue a and position j with residue b to show the coevolution level between them. Then, the correlation matrix can be denoised to show evolutional related sectors, which tend to be structurally and functionally related (see material and methods) [34], [36], [43]. With LHCGR and FSHR from all species, the correlation constant between each residue pair was shown in Fig. 5A and 5C, while the corresponding sectors were shown in Fig. 5B and 5D. The conservation degree of each position in LHCGR and FSHR was shown in Figure S9 and Figure S10, respectively.
Because ECD (including LRR and hinge region) and C-terminus are not conserved among species for GPHRs (Figure S9 and Figure S10), these two domains in both FSHR and LHCGR showed higher coevolution scores, which was not informative. Notably, several TMD residues showed coevolution with ECD residues. The mostly coevolved TMD parts were ECL1 and intracellular TM5-TM6 in both FSHR and LHCGR (Fig. 5A, 5C, shown by rectangles). Remarkbly, previous GPCRs studies indicate the intracellular TM5-TM6 are determinant for the receptor activation [44], [45].
In Fig. 5B, D, the residues were separated into different sectors according to their coevolution relationship. Blue sectors were distributed around CG- or FSH- binding pocket in LRR and hinge loop, functioning as a signal receptor domain in GPHRs. Red sectors located on hinge loop, ECL1, and TM5-TM6. They may play their role as a signal deliverer and the inclusion of the hinge loop confirmed that loop movements influenced signal transmission. Green sectors included the small molecule-binding pocket as well as the G protein-binding pocket for class A GPCRs. This coevolution analysis unraveled the relationship between ECD and ECL1, TM5-TM6, showed the importance of hinge loop in signal transfer, and reflected the retention of classical TMD signal pathway in GPHR.
Considering the conservation of the hinge helix and P10 loop, the coevolution analysis based on mutations was not able to capture their impact on TMD. We hence calculated the dynamical cross-correlation map (DCCM) to show the relationship of movements between residue pairs. The correlation between residue movements was shown as a DCCM in Fig. 6A and 6B [46]. Red and blue represented correlated and anti-correlated movements, respectively. To identify the correlations between the hinge helix and P10 to other parts, we labeled them in rectangles and visualized their movement relationships in Fig. 6C.
Fig. 6.
DCCM analysis for dynamics relationship between residues. (A, B) DCCM matrix for LHCGR-only (A) and LHCGR-CG (B) systems. Red and blue show correlated and anti-correlated movements between residues, respectively. Rectangles and arrows show key correlation domains. (C) Representive models showing dynamics relationships for hinge helix and P10. The color scheme is the same as (A) and (B). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Globally, the movement relationship was slightly stronger in LHCGR-CG than which in LHCGR-only, indicating that CG promoted correlated movement in LHCGR and contributed to signal transmission. In Fig. 6A and 6B, as the rectangles showed, both hinge helix (276–282) and P10 loop (350–359) are anti-correlated with TM5-TM6 movements. Fig. 6C also had deep blue color in the transducer-binding pocket for both the hinge helix and P10, suggesting that the movements of these domains were related to the movements of the G protein-binding pocket. Taken together, evolutionary and dynamics relationship analysis suggested the correlation between the hinge domain and the other subdomains, including LRR, ECL1, and G protein-binding pocket, consistent with our trajectory observations.
4. Discussion
Here, our all-atom MD simulations showed a unique hinge loop rotation in LHCGR upon the binding of its endogenous agonist CG. The rotation occurs with increased surface area and reduced interactions of the hinge loop compared with LHCGR-only. With loop rotation, the hinge helix-P10 region has specific downward movements, including the P10 loop with respect to TMD and the hinge helix with respect to ECL1, indicating an active-like conformation. In contrast, inactive-like conformation in LHCGR-only shows upward movements of the P10 loop and hinge helix. These movements correspond with known activation and inactivation mutations in the hinge helix-P10 domain. Also, the active-like conformation is related to the TMD expansion. Evolutionary and dynamics analysis suggest that conformational changes of hinge loop and ECD-TMD interface are correlated to TM5-TM6 movements at the intracellular side, inferring their roles in signal transmission. This work supplements the push-and-pull model of LHCGR activation by elucidating the roles of the hinge region in signal transmission using computational models.
Our simulation results underscore the importance of hinge helix-P10 conformation and provide a potential molecular basis for previous mutagenesis studies on the ECD-TMD interface [9], [15], [37]. Although P10 is shown as a flexible loop, its residue composition is critical to the activation of LHCGR and a single mutation is enough to decrease LHCGR activity [1], [14], [47]. Mutations other than S277I on the hinge helix also significantly change the activation property for LHCGR and its homolog thyroid stimulating hormone receptor (TSHR) [48]. Notably, hydrophobic mutations on S277 commonly lead to activation, while polar mutations cause inactivation [37]. It supports our assumption that 277–431 hydrophobic interactions make the hinge helix closer to ECL1 to promote active-like conformation in LHCGR.
A recent cryo-EM structure of TSHR shows a similar signal transmission induced by the endogenous glycoprotein hormone [49]. The interactions between hormone and hinge loop constrain the conformation of the loop to activate TSHR [49], [50]. Upon the agonist binding, the hinge helix of TSHR also moves towards ECL1, while its P10 loop stays away from ECL1, highly consistent with the ECD-TMD alteration observed in our MD simulations. In addition, an antibody interacting with the bottom of LRR activates TSHR without the dependence on the hinge loop [49]. It indicates the possibility to activate GPHRs via directly regulating the ECD-TMD interface.
From our signal transmission computational model, the hinge region plays functional roles in GPHR via interacting with ECL1. As N-terminal residues, the hinge region has been identified as a tethered agonist and their residue composition is critical to GPHR activation [48]. The N-terminus has been shown to interact with ECL3 and initiate activation of class A GPCRs, including melanocortin and chemokine receptors [51], [52], [53]. For class B and class C GPCRs, the N-terminus can also regulate ligand binding and activation [54], [55], [56]. Due to its flexibility, however, the N-terminus is not always solved in GPCR structures [31]. The observed activation effect of the N-terminus reminds attention to such a “vanished” part.
Our simulations have explored the conformational ensemble of the hinge loop of a typical GPHR. Since the clockwise rotation of the hinge loop is a unique property of LHCGR-CG and related to downstream signaling, maintaining such rotation might provide a new strategy for LHCGR activation. Besides, our sampling has shown the distinct dynamics of the ECD-TMD interface and investigated their influence on extracellular TMD. Considering the flexibility of the hinge domain and extracellular TMD, ensemble docking can be a proposed way to design targeting compounds [57], [58]. In addition, a covalent molecule connecting the hinge loop and ECD may perform a similar function as LH or CG and activate the downstream signal [59], [60]. The usage of such regulators is potential to change the ECD-TMD interface, thereby may promoting the effect of known allosteric modulators targeting TMD [15], [61]. With such dynamics, we did more than supplement the previous model for agonist effect but provided insights into the targeting drug design as well.
CRediT authorship contribution statement
Xinheng He: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Data curation, Writing – original draft, Visualization. Jia Duan: Methodology, Validation, Resources, Visualization. Yujie Ji: Validation. Lifen Zhao: Formal analysis. Hualiang Jiang: Supervision. Yi Jiang: Writing – review & editing, Supervision, Funding acquisition. H. Eric Xu: Conceptualization, Resources, Supervision, Funding acquisition. Xi Cheng: Conceptualization, Methodology, Investigation, Data curation, Writing – review & editing, Supervision, Project administration, Funding acquisition.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
This work was partially supported by the Shanghai Municipal Science and Technology Major Project (X.C. and H.E.X.); the Lingang Laboratory grant (LG202102-01-01 to X.C.); the Ministry of Science and Technology (China) grants (2018YFA0507002 to H.E.X.); the CAS Strategic Priority Research Program (XDB37030103 to H.E.X.); the National Natural Science Foundation of China (32130022 to H.E.X., 32171187 to Y.J., 82121005 to H.E.X. and Y.J.).
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.csbj.2022.11.039.
Contributor Information
Yi Jiang, Email: yjiang@lglab.ac.cn.
H. Eric Xu, Email: eric.xu@simm.ac.cn.
Xi Cheng, Email: xicheng@simm.ac.cn.
Appendix A. Supplementary data
The following are the Supplementary data to this article:
References
- 1.Narayan P, Ulloa-Aguirre A, Dias JA. Chapter 2 - Gonadotropin Hormones and Their Receptors. In Strauss JF, Barbieri RLBT-Y and JRE (Eighth E, editors., Philadelphia: Elsevier; 2019, p. 25–57.
- 2.Choi J., Smitz J. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol. 2014;383:203–213. doi: 10.1016/j.mce.2013.12.009. [DOI] [PubMed] [Google Scholar]
- 3.Jiang X., Liu H., Chen X., Chen P.-H., Fischer D., Sriraman V., et al. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc Natl Acad Sci U S A. 2012;109:12491–12496. doi: 10.1073/pnas.1206643109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yariz K.O., Walsh T., Uzak A., Spiliopoulos M., Duman D., Onalan G., et al. Inherited mutation of the luteinizing hormone/choriogonadotropin receptor (LHCGR) in empty follicle syndrome. Fertil Steril. 2011;96:125–130. doi: 10.1016/j.fertnstert.2011.05.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Theofanakis C., Drakakis P., Besharat A., Loutradis D. Human Chorionic Gonadotropin: The Pregnancy Hormone and More. Int J Mol Sci. 2017;18:1059. doi: 10.3390/ijms18051059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hansel W., Leuschner C., Enright F. Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases. Mol Cell Endocrinol. 2007;269:26–33. doi: 10.1016/j.mce.2006.06.017. [DOI] [PubMed] [Google Scholar]
- 7.Saberi S., Du Y.P., Christie M., Goldsbury C. Human chorionic gonadotropin increases β-cleavage of amyloid precursor protein in SH-SY5Y cells. Cell Mol Neurobiol. 2013;33:747–751. doi: 10.1007/s10571-013-9954-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cole L.A. HCG variants, the growth factors which drive human malignancies. Am J Cancer Res. 2012;2:22–35. [PMC free article] [PubMed] [Google Scholar]
- 9.Stavrou S.S., Zhu Y.S., Cai L.Q., Katz M.D., Herrera C., Defillo-Ricart M., et al. A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab. 1998;83:2091–2098. doi: 10.1210/jcem.83.6.4855. [DOI] [PubMed] [Google Scholar]
- 10.Cunha-Silva M., Brito V.N., Macedo D.B., Bessa D.S., Ramos C.O., Lima L.G., et al. Spontaneous fertility in a male patient with testotoxicosis despite suppression of FSH levels. Hum Reprod. 2018;33:914–918. doi: 10.1093/humrep/dey049. [DOI] [PubMed] [Google Scholar]
- 11.Lapthorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J., et al. Crystal structure of human chorionic gonadotropin. Nature. 1994;369:455–461. doi: 10.1038/369455a0. [DOI] [PubMed] [Google Scholar]
- 12.Ng A., Xavier R.J. Leucine-rich repeat (LRR) proteins: integrators of pattern recognition and signaling in immunity. Autophagy. 2011;7:1082–1084. doi: 10.4161/auto.7.9.16464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.de Graaf C., Song G., Cao C., Zhao Q., Wang M.-W., Wu B., et al. Extending the Structural View of Class B GPCRs. Trends Biochem Sci. 2017;42:946–960. doi: 10.1016/j.tibs.2017.10.003. [DOI] [PubMed] [Google Scholar]
- 14.Brüser A., Schulz A., Rothemund S., Ricken A., Calebiro D., Kleinau G., et al. The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases. J Biol Chem. 2016;291:508–520. doi: 10.1074/jbc.M115.701102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Duan J., Xu P., Cheng X., Mao C., Croll T., He X., et al. Structures of full-length glycoprotein hormone receptor signalling complexes. Nature. 2021;598:688–692. doi: 10.1038/s41586-021-03924-2. [DOI] [PubMed] [Google Scholar]
- 16.Ulloa-Aguirre A., Zariñán T., Jardón-Valadez E., Gutiérrez-Sagal R., Dias J.A. Structure-Function Relationships of the Follicle-Stimulating Hormone Receptor. Front Endocrinol (Lausanne) 2018;29:707. doi: 10.3389/fendo.2018.00707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Waterhouse A., Bertoni M., Bienert S., Studer G., Tauriello G., Gumienny R., et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296–W303. doi: 10.1093/nar/gky427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Søndergaard C.R., Olsson M.H.M., Rostkowski M., Jensen J.H. Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. J Chem Theory Comput. 2011;7:2284–2295. doi: 10.1021/ct200133y. [DOI] [PubMed] [Google Scholar]
- 19.Wu E.L., Cheng X., Jo S., Rui H., Song K.C., Dávila-Contreras E.M., et al. CHARMM-GUI membrane builder toward realistic biological membrane simulations. J Comput Chem. 2014;35:1997–2004. doi: 10.1002/jcc.23702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jo S., Cheng X., Lee J., Kim S., Park S.-J., Patel D.S., et al. CHARMM-GUI 10 years for biomolecular modeling and simulation. J Comput Chem. 2017;38:1114–1124. doi: 10.1002/jcc.24660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lee J., Cheng X., Swails J.M., Yeom M.S., Eastman P.K., Lemkul J.A., et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput. 2016;12:405–413. doi: 10.1021/acs.jctc.5b00935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Huang J., Rauscher S., Nawrocki G., Ran T., Feig M., de Groot B.L., et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods. 2017;14:71–73. doi: 10.1038/nmeth.4067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nosé S. A unified formulation of the constant temperature molecular dynamics methods. J Chem Phys. 1984;81:511–519. [Google Scholar]
- 24.Aoki K.M., Yonezawa F. Constant-pressure molecular-dynamics simulations of the crystal-smectic transition in systems of soft parallel spherocylinders. Phys Rev A, At Mol Opt Phys. 1992;46:6541–6549. doi: 10.1103/physreva.46.6541. [DOI] [PubMed] [Google Scholar]
- 25.Hess B. P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. J Chem Theory Comput. 2008;4:116–122. doi: 10.1021/ct700200b. [DOI] [PubMed] [Google Scholar]
- 26.Darden T., York D., Pedersen L. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089–10092. [Google Scholar]
- 27.Abraham M.J., Murtola T., Schulz R., Páll S., Smith J.C., Hess B., et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1–2:19–25. [Google Scholar]
- 28.Roe D.R., Cheatham T.E., III PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9:3084–3095. doi: 10.1021/ct400341p. [DOI] [PubMed] [Google Scholar]
- 29.Weiser J., Shenkin P.S., Still W.C. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) J Comput Chem. 1999;20:217–230. [Google Scholar]
- 30.Durrant J.D., Votapka L., Sørensen J., Amaro R.E. POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics. J Chem Theory Comput. 2014;10:5047–5056. doi: 10.1021/ct500381c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Munk C., Mutt E., Isberg V., Nikolajsen L.F., Bibbe J.M., Flock T., et al. An online resource for GPCR structure determination and analysis. Nat Methods. 2019;16:151–162. doi: 10.1038/s41592-018-0302-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Seo M.J., Heo J., Kim K., Chung K.Y., Yu W. Coevolution underlies GPCR-G protein selectivity and functionality. Sci Rep. 2021;11:7858. doi: 10.1038/s41598-021-87251-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Crooks G.E., Hon G., Chandonia J.-M., Brenner S.E. WebLogo: a sequence logo generator. Genome Res. 2004;14:1188–1190. doi: 10.1101/gr.849004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Halabi N., Rivoire O., Leibler S., Ranganathan R. Protein sectors: evolutionary units of three-dimensional structure. Cell. 2009;138:774–786. doi: 10.1016/j.cell.2009.07.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tunyasuvunakool K., Adler J., Wu Z., Green T., Zielinski M., Žídek A., et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596:590–596. doi: 10.1038/s41586-021-03828-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cong X., Zhang X., Liang X., He X., Tang Y., Zheng X., et al. Delineating the conformational landscape and intrinsic properties of the angiotensin II type 2 receptor using a computational study. Comput Struct. Biotechnol J. 2022 doi: 10.1016/j.csbj.2022.05.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nakabayashi K., Kudo M., Kobilka B., Hsueh A.J.W. Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. J Biol Chem. 2000;275:30264–30271. doi: 10.1074/jbc.M005568200. [DOI] [PubMed] [Google Scholar]
- 38.Zhuang Y., Wang Y., He B., He X., Zhou X.E., Guo S., et al. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor. Cell. 2022;185:4361–4375. doi: 10.1016/j.cell.2022.09.041. [DOI] [PubMed] [Google Scholar]
- 39.He X.-H., You C.-Z., Jiang H.-L., Jiang Y., Xu H.E., Cheng X. AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors. Acta Pharmacol Sin. 2022 doi: 10.1038/s41401-022-00938-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Tan Y., Xu P., Huang S., Yang G., Zhou F., He X., et al. Structural insights into the ligand binding and G(i) coupling of serotonin receptor 5-HT(5A) Cell Discov. 2022;8:50. doi: 10.1038/s41421-022-00412-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Venkatakrishnan A.J., Deupi X., Lebon G., Tate C.G., Schertler G.F., Madan B.M. Molecular signatures of G-protein-coupled receptors. Nature. 2013;494:185–194. doi: 10.1038/nature11896. [DOI] [PubMed] [Google Scholar]
- 42.Suomivuori C.-M., Latorraca N.R., Wingler L.M., Eismann S., King M.C., Kleinhenz A.L.W., et al. Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor. Science. 2020;367:881–887. doi: 10.1126/science.aaz0326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Shulman A.I., Larson C., Mangelsdorf D.J., Ranganathan R. Structural determinants of allosteric ligand activation in RXR heterodimers. Cell. 2004;116:417–429. doi: 10.1016/s0092-8674(04)00119-9. [DOI] [PubMed] [Google Scholar]
- 44.Zhou Q., Yang D., Wu M., Guo Y., Guo W., Zhong L., et al. Common activation mechanism of class A GPCRs. Elife. 2019;8:e50279. doi: 10.7554/eLife.50279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Lu S., He X., Yang Z., Chai Z., Zhou S., Wang J., et al. Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design. Nat Commun. 2021;12:4721. doi: 10.1038/s41467-021-25020-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Swaminathan S., Harte W.E., Jr, Beveridge D.L. Investigation of domain structure in proteins via molecular dynamics simulation: application to HIV-1 protease dimer. J Am Chem Soc. 1991;113:2717–2721. [Google Scholar]
- 47.Althumairy D., Zhang X., Baez N., Barisas G., Roess D.A., Bousfield G.R., et al. Glycoprotein G-protein Coupled Receptors in Disease: Luteinizing Hormone Receptors and Follicle Stimulating Hormone Receptors. Dis (Basel, Switzerland) 2020;8:E35. doi: 10.3390/diseases8030035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Schulze A., Kleinau G., Neumann S., Scheerer P., Schöneberg T., Brüser A. The intramolecular agonist is obligate for activation of glycoprotein hormone receptors. FASEB J. 2020;34:11243–11256. doi: 10.1096/fj.202000100R. [DOI] [PubMed] [Google Scholar]
- 49.Duan J., Xu P., Luan X., Ji Y., He X., Song N., et al. Hormone- and antibody-mediated activation of the thyrotropin receptor. Nature. 2022;609:854–859. doi: 10.1038/s41586-022-05173-3. [DOI] [PubMed] [Google Scholar]
- 50.Jaeschke H., Schaarschmidt J., Günther R., Mueller S. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH. Endocrinology. 2011;152:3986–3996. doi: 10.1210/en.2011-1389. [DOI] [PubMed] [Google Scholar]
- 51.Zhang H., Chen L.-N., Yang D., Mao C., Shen Q., Feng W., et al. Structural insights into ligand recognition and activation of the melanocortin-4 receptor. Cell Res. 2021;31:1163–1175. doi: 10.1038/s41422-021-00552-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Ersoy B.A., Pardo L., Zhang S., Thompson D.A., Millhauser G., Govaerts C., et al. Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. Nat Chem Biol. 2012;8:725–730. doi: 10.1038/nchembio.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Szpakowska M., Fievez V., Arumugan K., van Nuland N., Schmit J.-C., Chevigné A. Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors. Biochem Pharmacol. 2012;84:1366–1380. doi: 10.1016/j.bcp.2012.08.008. [DOI] [PubMed] [Google Scholar]
- 54.Alexander S.P.H., Christopoulos A., Davenport A.P., Kelly E., Mathie A., Peters J.A., et al. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. Br J Pharmacol. 2019;176(Suppl):S21–S. doi: 10.1111/bph.14748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Lagerström M.C., Schiöth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008;7:339–357. doi: 10.1038/nrd2518. [DOI] [PubMed] [Google Scholar]
- 56.Ping Y.-Q., Xiao P., Yang F., Zhao R.-J., Guo S.-C., Yan X., et al. Structural basis for the tethered peptide activation of adhesion GPCRs. Nature. 2022;604:763–770. doi: 10.1038/s41586-022-04619-y. [DOI] [PubMed] [Google Scholar]
- 57.Ruan H., Sun Q., Zhang W., Liu Y., Lai L. Targeting intrinsically disordered proteins at the edge of chaos. Drug Discov Today. 2019;24:217–227. doi: 10.1016/j.drudis.2018.09.017. [DOI] [PubMed] [Google Scholar]
- 58.Stelzer A.C., Frank A.T., Kratz J.D., Swanson M.D., Gonzalez-Hernandez M.J., Lee J., et al. Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble. Nat Chem Biol. 2011;7:553–559. doi: 10.1038/nchembio.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Habazettl J., Allan M., Jensen P.R., Sass H.-J., Thompson C.J., Grzesiek S. Structural basis and dynamics of multidrug recognition in a minimal bacterial multidrug resistance system. Proc Natl Acad Sci U S A. 2014;111:E5498–E5507. doi: 10.1073/pnas.1412070111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Zhang W., Pei J., Lai L. Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine Residues. J Chem Inf Model. 2017;57:1453–1460. doi: 10.1021/acs.jcim.7b00163. [DOI] [PubMed] [Google Scholar]
- 61.van Koppen C.J., Zaman G.J.R., Timmers C.M., Kelder J., Mosselman S., van de Lagemaat R., et al. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:503–514. doi: 10.1007/s00210-008-0318-3. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.







